Oric Pharmaceuticals Inc
NASDAQ:ORIC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
US |
|
Findi Ltd
ASX:FND
|
AU |
|
Polycab India Ltd
NSE:POLYCAB
|
IN |
|
S
|
Schlumberger NV
XHAM:SCL
|
US |
|
Meta Platforms Inc
NASDAQ:META
|
US |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
|
Arabian Centres Company SJSC
SAU:4321
|
SA |
|
A
|
AXA SA
F:AXA
|
FR |
|
Heineken NV
AEX:HEIA
|
NL |
|
Thalassa Holdings Ltd
LSE:THAL
|
VG |
|
W
|
Westport Fuel Systems Inc
NASDAQ:WPRT
|
CA |
|
ProPetro Holding Corp
NYSE:PUMP
|
US |
|
I
|
Ingevec SA
SGO:INGEVEC
|
CL |
|
Columbia Sportswear Co
NASDAQ:COLM
|
US |
|
Axon Enterprise Inc
NASDAQ:AXON
|
US |
Shareholder Yield
Current shareholder yield for ORIC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ORIC Price
Oric Pharmaceuticals Inc
| Average Annual Return | -12.2% |
| Standard Deviation of Annual Returns | 48.46% |
| Max Drawdown | -90% |
| Market Capitalization | 861m USD |
| Shares Outstanding | 100 360 000 |
| Percentage of Shares Shorted | 21.49% |
